Liver transplantation in children

Slides:

Advertisements

Similar presentations

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.

Volume 63, Issue 1, Pages (July 2015)

Volume 46, Issue 3, Pages (March 2007)

Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs

Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen

Inflammasomes in liver diseases

Volume 50, Issue 4, Pages (April 2009)

MELD: the holy grail of organ allocation?

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review Christian Thoma, Christopher P. Day, Michael.

Liver transplantation using Donation after Cardiac Death donors

Volume 68, Issue 5, Pages (May 2018)

EUROPEAN LIVER TRANSPLANT REGISTRY

Volume 61, Issue 6, Pages (December 2014)

Reactive oxygen species in the normal and acutely injured liver

Matthew T. Kitson, Stuart K. Roberts Journal of Hepatology

Immigration and viral hepatitis

Marcus-Alexander Wörns, Peter Robert Galle Journal of Hepatology

Volume 66, Issue 1, Pages 1-4 (January 2017)

Living donor liver transplantation: is the hype over?

What lessons have we learned in pediatric liver transplantation?

Reply to: “DCD consensus and futility in liver transplantation”

Volume 44, Pages S19-S24 (January 2006)

The place of downstaging for hepatocellular carcinoma

Reply to: “Low free T3 levels are related to early mortality in patients with decompensated cirrhosis and acute-on chronic liver failure” Rakhi Maiwall,

Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs

Familial amyloid polyneuropathy and liver transplantation

Hepatitis C core protein – The “core” of immune deception?

Volume 61, Issue 1, Pages S108-S119 (November 2014)

Volume 70, Issue 1, Pages (January 2019)

Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study Gyuri Kim, Suk-Yong Jang, Chung.

Volume 61, Issue 1, Pages S69-S78 (November 2014)

Volume 62, Issue 3, Pages (March 2015)

Volume 43, Issue 4, Pages (October 2005)

Who should get a liver graft?

EASL Clinical Practice Guidelines: Wilson’s disease

De novo autoimmune hepatitis after liver transplantation

Roberto de Franchis, Aleksander Krag Journal of Hepatology

Age and liver transplantation

EASL Recognition Award Recipient 2017: Prof. Giorgina Mieli-Vergani

Volume 57, Issue 5, Pages (November 2012)

Volume 59, Issue 4, Pages (October 2013)

Volume 50, Issue 4, Pages (April 2009)

Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong

Portal vein thrombosis, cirrhosis, and liver transplantation

Immigration and viral hepatitis

Volume 57, Issue 3, Pages (September 2012)

Evolution of liver transplantation for hepatocellular carcinoma

The potential of induced pluripotent stem cell derived hepatocytes

Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability Markus Cornberg,

Global burden of alcoholic liver diseases

HCV targeting of patients with cirrhosis

The impact of intestinal microflora on serum bilirubin levels

Volume 63, Issue 1, Pages (July 2015)

Familial amyloidosis: Great progress for an orphan disease

The use of hemospray in portal hypertensive bleeding; a case series

Hepatorenal syndrome, MELD score and liver transplantation: An evolving issue with relevant implications for clinical practice Paolo Angeli, Pere Gines

J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer

Shunt dysfunction: Is it suitable as the primary end point in transjugular intrahepatic portosystemic shunt trials? Jingzhi Cai, Wengang Guo, Chuangye.

New trials and results in systemic treatment of HCC

Pathogenesis of cholestatic hepatitis C

Donor-recipient matching: Myths and realities

Chimeric mouse model of hepatitis B virus infection

Comment on the article “Age and liver transplantation”

The relationship between age and fat infiltration in liver and muscle

Volume 44, Issue 2, Pages (February 2006)

MELD: the holy grail of organ allocation?

Thierry Gustot, Rajiv Jalan Journal of Hepatology

Volume 70, Issue 5, Pages (May 2019)

Presentation transcript:

Liver transplantation in children Paolo Muiesan, Diego Vergani, Giorgina Mieli-Vergani Journal of Hepatology Volume 46, Issue 2, Pages 340-348 (February 2007) DOI: 10.1016/j.jhep.2006.11.006 Copyright © 2006 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Implantation of left lateral segment graft. Journal of Hepatology 2007 46, 340-348DOI: (10.1016/j.jhep.2006.11.006) Copyright © 2006 European Association for the Study of the Liver Terms and Conditions

Fig. 2 European Liver Transplant Registry data for patient and graft survivals according to the recipient’s age (01/1988–12/2004). Journal of Hepatology 2007 46, 340-348DOI: (10.1016/j.jhep.2006.11.006) Copyright © 2006 European Association for the Study of the Liver Terms and Conditions